semaglutide aspiration during anesthesia case report 2023 Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a semaglutide aspiration during anesthesia case

The data described herein reflect exposure to QSYMIA in two 1-year, randomized, double-blind, placebo-controlled, multicenter clinical trials and two supportive trials in 2,318 adult patients with overweight or obesity [936 (40%) patients with hypertension, 309 (13%) patients with type 2 diabetes mellitus, 808 (35%) patients with BMI greater than 40 kg/m 2] exposed for a mean duration of 298 days

This broader mechanism may explain why retatrutide has shown greater weight loss potential in clinical trials

Retatrutide activates three simultaneously: GLP-1, GIP, and glucagon

Directions: Standard Dosage: Take 1-2 capsules before bedtime or on an empty stomach

Medication is billed separately per fill